Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

NATZO 8 TABLETS 8 mg

Approval Number

SIN15424P

Drug Name

NATZO 8 TABLETS 8 mg

Product Name

NATZO 8 TABLETS 8 mg

Approval Date

February 9, 2018

Registrant

NATCO PHARMA ASIA PTE. LTD.

Licence Holder

NATCO PHARMA ASIA PTE. LTD.

Regulatory Information

Registrant

NATCO PHARMA ASIA PTE. LTD.

Licence Holder

NATCO PHARMA ASIA PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

A04AA01

ATC Item Name

ondansetron

Manufacturer Information

Pharmaceutical Manufacturer

NATCO PHARMA ASIA PTE. LTD.

Manufacturers

Natco Pharma Limited - Pharma Division

Active Ingredients

Ingredient Name

Ondansetron Hydrochloride Dihydrate 10 mg EQV Ondansetron

Strength

8.0 mg

Drug MonographOndansetron

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy